Frenkel Ran
Insider CIK 1623108 · KPTI EVP, WW Development Operations
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KPTI Karyopharm Therapeutics In | A Award deriv | 2022-02-28 | 2022-03-02 | 90,000 | — | $0 | 90,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2022-02-28 | 2022-03-02 | 68,250 | — | $0 | 169,953 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2022-02-28 | 2022-03-02 | 1,663 | $10.24 | $17.0K | 168,290 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2022-02-17 | 2022-02-22 | 2,929 | $12.12 | $35.5K | 101,703 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2022-02-07 | 2022-02-09 | 1,991 | $9.86 | $19.6K | 104,632 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2021-02-25 | 2021-03-01 | 59,968 | — | $0 | 59,968 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2021-02-25 | 2021-03-01 | 22,013 | — | $0 | 104,439 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2021-02-18 | 2021-02-22 | 2,887 | $14.83 | $42.8K | 46,126 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2021-02-15 | 2021-02-17 | 9,675 | — | $0 | 19,350 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2021-02-15 | 2021-02-17 | 9,675 | — | $0 | 49,013 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2021-02-11 | 2021-02-17 | 2,046 | $15.52 | $31.8K | 39,338 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2021-02-05 | 2021-02-09 | 5,650 | — | $0 | 16,950 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2021-02-05 | 2021-02-09 | 5,650 | — | $0 | 41,384 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-05-07 | 2020-05-11 | 1,974 | $20.00 | $39.5K | 35,088 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-02-19 | 2020-02-21 | 2,975 | $16.48 | $49.0K | 36,066 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-02-15 | 2020-02-19 | 9,675 | — | $0 | 29,025 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-02-15 | 2020-02-19 | 9,675 | — | $0 | 39,041 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2020-02-05 | 2020-02-07 | 22,600 | — | $0 | 22,600 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2020-02-05 | 2020-02-07 | 60,600 | — | $0 | 60,600 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2019-02-15 | 2019-02-19 | 38,700 | — | $0 | 38,700 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2019-02-15 | 2019-02-19 | 102,800 | — | $0 | 102,800 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2018-01-24 | 2018-01-25 | 60,000 | — | $0 | 60,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2017-11-07 | 2017-11-09 | 4,958 | $11.25 | $55.8K | 24,733 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2017-11-05 | 2017-11-06 | 15,000 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2017-11-05 | 2017-11-06 | 15,000 | — | $0 | 29,691 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2017-01-20 | 2017-01-24 | 100,000 | — | $0 | 100,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2016-11-14 | 2016-11-15 | 3,309 | $10.06 | $33.3K | 14,691 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2016-11-05 | 2016-11-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2016-11-05 | 2016-11-08 | 15,000 | — | $0 | 18,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2016-01-15 | 2016-01-20 | 75,000 | — | $0 | 75,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2015-11-05 | 2015-11-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | P Buy | 2015-04-07 | 2015-04-08 | 2,000 | $33.00 | $66.0K | 3,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | P Buy | 2015-04-06 | 2015-04-08 | 1,000 | $29.43 | $29.4K | 1,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2014-11-19 | 2014-11-21 | 160,000 | — | $0 | 160,000 | SEC↗ |